4
Changes in Ownership
CRISPR Therapeutics AG Filed Acc 0000899243-18-010985
Director sold 222,258 shares at an average $50.11 ($11,136,437)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bolzon Bradley J PhD Director | 2018-04-26 | Sale | −185,075 | $50.11 | $9,274,108 | 1,334,430 | I |
| Bolzon Bradley J PhD Director | 2018-04-26 | Sale | −5,430 | $50.12 | $272,152 | 39,152 | I |
| Bolzon Bradley J PhD Director | 2018-04-26 | Sale | −6,019 | $50.12 | $301,672 | 43,400 | I |
| Bolzon Bradley J PhD Director | 2018-04-26 | Sale | −14,086 | $50.11 | $705,849 | 101,559 | I |
| Bolzon Bradley J PhD Director | 2018-04-27 | Sale | −10,236 | $50.02 | $512,005 | 1,324,194 | I |
| Bolzon Bradley J PhD Director | 2018-04-27 | Sale | −300 | $50.08 | $15,024 | 38,852 | I |
| Bolzon Bradley J PhD Director | 2018-04-27 | Sale | −333 | $50.01 | $16,653 | 43,067 | I |
| Bolzon Bradley J PhD Director | 2018-04-27 | Sale | −779 | $50.03 | $38,973 | 100,780 | I |
| Open-market sales · 222,258 sh · avg $50.11 · $11,136,437 | |||||||
Loading xslF345X03/doc4.xml…